Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Prospective, Multicenter Study of the MTOR Inhibitor Everolimus (RAD001) As Primary Therapy in Waldenstrom's Macroglobulinemia 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Treon, S. P., Tripsas, C. K., Ioakimidis, L., Warren, D., Patterson, C., Heffner, L., Eradat, H., Gregory, S. A., Thomas, S., Advani, R., Baz, R., Badros, A. Z., Matous, J., Anderson, K. C., Ghobrial, I. M. AMER SOC HEMATOLOGY. 2011: 1273–74
View details for Web of Science ID 000299597104302